Total raised
$385K
Last: Seed 2021-06
Stage
Seed
Founded
2016
Headcount
23
HQ
פארק תעשיות בר-לב
Sector
Health Tech & Life Sciences
About
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution. ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability, reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.
Funding history · 2 rounds · $385K total
2021-06
Seed
Undisclosed
2020-08
Equity crowdfunding
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Tags
medical-technologiespatientsbiotechnologymedical-deviceshospitalscancercell-therapyimmunologymanufacturinggenetic-engineeringautomationmonitoring